DIABETIC MACULAR EDEMA (DME)
Clinical trials for DIABETIC MACULAR EDEMA (DME) explained in plain language.
Never miss a new study
Get alerted when new DIABETIC MACULAR EDEMA (DME) trials appear
Sign up with your email to follow new studies for DIABETIC MACULAR EDEMA (DME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection shows promise for common vision loss conditions
Disease control CompletedThis early-stage study tested the safety of two different versions of an experimental eye injection called OLN324. The trial involved 164 adults with either wet age-related macular degeneration or diabetic macular edema, two conditions that can cause vision loss. Researchers want…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE1 • Sponsor: Ollin Biosciences, Inc. • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
New eye injection tested for common causes of vision loss
Disease control CompletedThis early-stage study tested a new eye injection called EYE103. It aimed to check its safety and find the best dose for people with vision loss from diabetic macular edema (DME) or 'wet' age-related macular degeneration (NVAMD). For DME, it was tested alone; for NVAMD, it was te…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Doctors track Real-World results of Vision-Saving eye injections
Disease control CompletedThis study observed how well an eye injection called brolucizumab worked in everyday medical practice for patients with two common causes of vision loss: 'wet' age-related macular degeneration (AMD) and diabetic macular edema (DME). It followed 572 patients in Germany for up to t…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC